Global and United States Breast Cancer Testing Market Report & Forecast 2023-2028

Report ID: 1872744 | Published Date: Jan 2025 | No. of Page: 99 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Breast Cancer Testing Revenue in Breast Cancer Testing Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Breast Cancer Testing Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Breast Cancer Testing Market Size for the Year 2017-2028
        1.2.2 Global Breast Cancer Testing Market Size for the Year 2017-2028
    1.3 Breast Cancer Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Breast Cancer Testing in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Breast Cancer Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Breast Cancer Testing Market Dynamics
        1.4.1 Breast Cancer Testing Industry Trends
        1.4.2 Breast Cancer Testing Market Drivers
        1.4.3 Breast Cancer Testing Market Challenges
        1.4.4 Breast Cancer Testing Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Breast Cancer Testing by Type
    2.1 Breast Cancer Testing Market Segment by Type
        2.1.1 Screening Tests
        2.1.2 Diagnostic Tests
        2.1.3 Monitoring Tests
    2.2 Global Breast Cancer Testing Market Size by Type (2017, 2022 & 2028)
    2.3 Global Breast Cancer Testing Market Size by Type (2017-2028)
    2.4 United States Breast Cancer Testing Market Size by Type (2017, 2022 & 2028)
    2.5 United States Breast Cancer Testing Market Size by Type (2017-2028)
3 Breast Cancer Testing by Application
    3.1 Breast Cancer Testing Market Segment by Application
        3.1.1 Non-invasive Breast Cancer
        3.1.2 Invasive Breast Cancer
    3.2 Global Breast Cancer Testing Market Size by Application (2017, 2022 & 2028)
    3.3 Global Breast Cancer Testing Market Size by Application (2017-2028)
    3.4 United States Breast Cancer Testing Market Size by Application (2017, 2022 & 2028)
    3.5 United States Breast Cancer Testing Market Size by Application (2017-2028)
4 Global Breast Cancer Testing Competitor Landscape by Company
    4.1 Global Breast Cancer Testing Market Size by Company
        4.1.1 Top Global Breast Cancer Testing Companies Ranked by Revenue (2021)
        4.1.2 Global Breast Cancer Testing Revenue by Player (2017-2022)
    4.2 Global Breast Cancer Testing Concentration Ratio (CR)
        4.2.1 Breast Cancer Testing Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Breast Cancer Testing in 2021
        4.2.3 Global Breast Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Breast Cancer Testing Headquarters, Revenue in Breast Cancer Testing Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Breast Cancer Testing Headquarters and Area Served
        4.3.2 Global Breast Cancer Testing Companies Revenue in Breast Cancer Testing Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Breast Cancer Testing Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Breast Cancer Testing Market Size by Company
        4.5.1 Top Breast Cancer Testing Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Breast Cancer Testing Revenue by Players (2020, 2021 & 2022)
5 Global Breast Cancer Testing Market Size by Region
    5.1 Global Breast Cancer Testing Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Breast Cancer Testing Market Size by Region (2017-2028)
        5.2.1 Global Breast Cancer Testing Market Size by Region: 2017-2022
        5.2.2 Global Breast Cancer Testing Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Breast Cancer Testing Market Size YoY Growth 2017-2028
        6.1.2 North America Breast Cancer Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Breast Cancer Testing Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Breast Cancer Testing Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Breast Cancer Testing Market Size YoY Growth 2017-2028
        6.3.2 Europe Breast Cancer Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Breast Cancer Testing Market Size YoY Growth 2017-2028
        6.4.2 Latin America Breast Cancer Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Breast Cancer Testing Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Breast Cancer Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Abbott
        7.1.1 Abbott Company Details
        7.1.2 Abbott Business Overview
        7.1.3 Abbott Breast Cancer Testing Introduction
        7.1.4 Abbott Revenue in Breast Cancer Testing Business (2017-2022)
        7.1.5 Abbott Recent Development
    7.2 Alere
        7.2.1 Alere Company Details
        7.2.2 Alere Business Overview
        7.2.3 Alere Breast Cancer Testing Introduction
        7.2.4 Alere Revenue in Breast Cancer Testing Business (2017-2022)
        7.2.5 Alere Recent Development
    7.3 Becton Dickinson
        7.3.1 Becton Dickinson Company Details
        7.3.2 Becton Dickinson Business Overview
        7.3.3 Becton Dickinson Breast Cancer Testing Introduction
        7.3.4 Becton Dickinson Revenue in Breast Cancer Testing Business (2017-2022)
        7.3.5 Becton Dickinson Recent Development
    7.4 BioMerieux
        7.4.1 BioMerieux Company Details
        7.4.2 BioMerieux Business Overview
        7.4.3 BioMerieux Breast Cancer Testing Introduction
        7.4.4 BioMerieux Revenue in Breast Cancer Testing Business (2017-2022)
        7.4.5 BioMerieux Recent Development
    7.5 Roche
        7.5.1 Roche Company Details
        7.5.2 Roche Business Overview
        7.5.3 Roche Breast Cancer Testing Introduction
        7.5.4 Roche Revenue in Breast Cancer Testing Business (2017-2022)
        7.5.5 Roche Recent Development
    7.6 GE Healthcare
        7.6.1 GE Healthcare Company Details
        7.6.2 GE Healthcare Business Overview
        7.6.3 GE Healthcare Breast Cancer Testing Introduction
        7.6.4 GE Healthcare Revenue in Breast Cancer Testing Business (2017-2022)
        7.6.5 GE Healthcare Recent Development
    7.7 Hologic
        7.7.1 Hologic Company Details
        7.7.2 Hologic Business Overview
        7.7.3 Hologic Breast Cancer Testing Introduction
        7.7.4 Hologic Revenue in Breast Cancer Testing Business (2017-2022)
        7.7.5 Hologic Recent Development
    7.8 Philips
        7.8.1 Philips Company Details
        7.8.2 Philips Business Overview
        7.8.3 Philips Breast Cancer Testing Introduction
        7.8.4 Philips Revenue in Breast Cancer Testing Business (2017-2022)
        7.8.5 Philips Recent Development
    7.9 PerkinElmer
        7.9.1 PerkinElmer Company Details
        7.9.2 PerkinElmer Business Overview
        7.9.3 PerkinElmer Breast Cancer Testing Introduction
        7.9.4 PerkinElmer Revenue in Breast Cancer Testing Business (2017-2022)
        7.9.5 PerkinElmer Recent Development
    7.10 Quest Diagnostics
        7.10.1 Quest Diagnostics Company Details
        7.10.2 Quest Diagnostics Business Overview
        7.10.3 Quest Diagnostics Breast Cancer Testing Introduction
        7.10.4 Quest Diagnostics Revenue in Breast Cancer Testing Business (2017-2022)
        7.10.5 Quest Diagnostics Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Breast Cancer Testing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Breast Cancer Testing Market Trends
    Table 3. Breast Cancer Testing Market Drivers
    Table 4. Breast Cancer Testing Market Challenges
    Table 5. Breast Cancer Testing Market Restraints
    Table 6. Global Breast Cancer Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Breast Cancer Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Breast Cancer Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Breast Cancer Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Breast Cancer Testing Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Breast Cancer Testing Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Breast Cancer Testing Revenue Share by Player, 2017-2022
    Table 13. Global Breast Cancer Testing Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Breast Cancer Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Testing as of 2021)
    Table 15. Top Players of Breast Cancer Testing in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Breast Cancer Testing Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Breast Cancer Testing Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Breast Cancer Testing Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Breast Cancer Testing Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Breast Cancer Testing Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Breast Cancer Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Breast Cancer Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Breast Cancer Testing Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Breast Cancer Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Breast Cancer Testing Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Breast Cancer Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Breast Cancer Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Breast Cancer Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Abbott Company Details
    Table 31. Abbott Business Overview
    Table 32. Abbott Breast Cancer Testing Product
    Table 33. Abbott Revenue in Breast Cancer Testing Business (2017-2022) & (US$ Million)
    Table 34. Abbott Recent Development
    Table 35. Alere Company Details
    Table 36. Alere Business Overview
    Table 37. Alere Breast Cancer Testing Product
    Table 38. Alere Revenue in Breast Cancer Testing Business (2017-2022) & (US$ Million)
    Table 39. Alere Recent Development
    Table 40. Becton Dickinson Company Details
    Table 41. Becton Dickinson Business Overview
    Table 42. Becton Dickinson Breast Cancer Testing Product
    Table 43. Becton Dickinson Revenue in Breast Cancer Testing Business (2017-2022) & (US$ Million)
    Table 44. Becton Dickinson Recent Development
    Table 45. BioMerieux Company Details
    Table 46. BioMerieux Business Overview
    Table 47. BioMerieux Breast Cancer Testing Product
    Table 48. BioMerieux Revenue in Breast Cancer Testing Business (2017-2022) & (US$ Million)
    Table 49. BioMerieux Recent Development
    Table 50. Roche Company Details
    Table 51. Roche Business Overview
    Table 52. Roche Breast Cancer Testing Product
    Table 53. Roche Revenue in Breast Cancer Testing Business (2017-2022) & (US$ Million)
    Table 54. Roche Recent Development
    Table 55. GE Healthcare Company Details
    Table 56. GE Healthcare Business Overview
    Table 57. GE Healthcare Breast Cancer Testing Product
    Table 58. GE Healthcare Revenue in Breast Cancer Testing Business (2017-2022) & (US$ Million)
    Table 59. GE Healthcare Recent Development
    Table 60. Hologic Company Details
    Table 61. Hologic Business Overview
    Table 62. Hologic Breast Cancer Testing Product
    Table 63. Hologic Revenue in Breast Cancer Testing Business (2017-2022) & (US$ Million)
    Table 64. Hologic Recent Development
    Table 65. Philips Company Details
    Table 66. Philips Business Overview
    Table 67. Philips Breast Cancer Testing Product
    Table 68. Philips Revenue in Breast Cancer Testing Business (2017-2022) & (US$ Million)
    Table 69. Philips Recent Development
    Table 70. PerkinElmer Company Details
    Table 71. PerkinElmer Business Overview
    Table 72. PerkinElmer Breast Cancer Testing Product
    Table 73. PerkinElmer Revenue in Breast Cancer Testing Business (2017-2022) & (US$ Million)
    Table 74. PerkinElmer Recent Development
    Table 75. Quest Diagnostics Company Details
    Table 76. Quest Diagnostics Business Overview
    Table 77. Quest Diagnostics Breast Cancer Testing Product
    Table 78. Quest Diagnostics Revenue in Breast Cancer Testing Business (2017-2022) & (US$ Million)
    Table 79. Quest Diagnostics Recent Development
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
List of Figures
    Figure 1. Breast Cancer Testing Product Picture
    Figure 2. Global Breast Cancer Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Breast Cancer Testing Market Size 2017-2028 (US$ Million)
    Figure 4. United States Breast Cancer Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Breast Cancer Testing Market Size 2017-2028 (US$ Million)
    Figure 6. United States Breast Cancer Testing Market Share in Global 2017-2028
    Figure 7. Breast Cancer Testing Report Years Considered
    Figure 8. Product Picture of Screening Tests
    Figure 9. Product Picture of Diagnostic Tests
    Figure 10. Product Picture of Monitoring Tests
    Figure 11. Global Breast Cancer Testing Market Share by Type in 2022 & 2028
    Figure 12. Global Breast Cancer Testing Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Breast Cancer Testing Market Share by Type (2017-2028)
    Figure 14. United States Breast Cancer Testing Market Share by Type in 2022 & 2028
    Figure 15. United States Breast Cancer Testing Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Breast Cancer Testing Market Share by Type (2017-2028)
    Figure 17. Product Picture of Non-invasive Breast Cancer
    Figure 18. Product Picture of Invasive Breast Cancer
    Figure 19. Global Breast Cancer Testing Market Share by Application in 2022 & 2028
    Figure 20. Global Breast Cancer Testing Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Breast Cancer Testing Market Share by Application (2017-2028)
    Figure 22. United States Breast Cancer Testing Market Share by Application in 2022 & 2028
    Figure 23. United States Breast Cancer Testing Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Breast Cancer Testing Market Share by Application (2017-2028)
    Figure 25. North America Breast Cancer Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Breast Cancer Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Breast Cancer Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Breast Cancer Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Breast Cancer Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Breast Cancer Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Abbott Revenue Growth Rate in Breast Cancer Testing Business (2017-2022)
    Figure 54. Alere Revenue Growth Rate in Breast Cancer Testing Business (2017-2022)
    Figure 55. Becton Dickinson Revenue Growth Rate in Breast Cancer Testing Business (2017-2022)
    Figure 56. BioMerieux Revenue Growth Rate in Breast Cancer Testing Business (2017-2022)
    Figure 57. Roche Revenue Growth Rate in Breast Cancer Testing Business (2017-2022)
    Figure 58. GE Healthcare Revenue Growth Rate in Breast Cancer Testing Business (2017-2022)
    Figure 59. Hologic Revenue Growth Rate in Breast Cancer Testing Business (2017-2022)
    Figure 60. Philips Revenue Growth Rate in Breast Cancer Testing Business (2017-2022)
    Figure 61. PerkinElmer Revenue Growth Rate in Breast Cancer Testing Business (2017-2022)
    Figure 62. Quest Diagnostics Revenue Growth Rate in Breast Cancer Testing Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Alere
Becton Dickinson
BioMerieux
Roche
GE Healthcare
Hologic
Philips
PerkinElmer
Quest Diagnostics
Frequently Asked Questions
Breast Cancer Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Breast Cancer Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Breast Cancer Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports